Making Tomorrow's Medicines

Fit for Purpose

Tony Hitchcock
Contributor: Tony Hitchcock
Posted: 09/21/2015

At Cobra we have worked on the development of both naked plasmid DNA and viral gene therapy products for over 20 years. After some rather extended development times, it has been very rewarding to see a number progress out of Phase II clinical studies and customers wanting to take these products into Phase III studies.

[inlinead]

Tony Hitchcock
Contributor: Tony Hitchcock
Posted: 09/21/2015